Sysco Corporation (BIT:1SYY)

Aerovate Therapeutics Revenue

In the fiscal year ending June 28, 2025, Sysco had annual revenue of $81.37B USD with 3.20% growth. Sysco had revenue of $21.14B in the quarter ending June 28, 2025, with 2.83% growth.

• Revenue: $81.37B
• Revenue Growth: +3.20%
• P/S Ratio: 0.48
• Revenue / Employee: $1.08M
• Employees: 75,000
• Market Cap: 33.03B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 28, 2025	81.37B	2.53B	3.20%
Jun 29, 2024	78.84B	2.52B	3.30%
Jul 1, 2023	76.33B	7.69B	11.20%
Jul 2, 2022	68.64B	17.34B	33.80%
Jul 3, 2021	51.30B	-1.60B	-3.02%